10-Q 1 d10q.htm FORM 10-Q Form 10-Q
Table of Contents

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 10-Q

 

 

(Mark One)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended October 1, 2010

OR

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from              to             

Commission File Number 0-18655

 

 

EXPONENT, INC.

(Exact name of registrant as specified in its charter)

 

 

 

DELAWARE   77-0218904

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

 

149 COMMONWEALTH DRIVE, MENLO PARK, CALIFORNIA   94025
(Address of principal executive office)   (Zip Code)

Registrant’s telephone number, including area code (650) 326-9400

 

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  ¨    No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. (See definition of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act).

 

Large accelerated filer   ¨    Accelerated filer   x
Non-accelerated filer   ¨  (Do not check if a smaller reporting company)    Smaller reporting company   ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ¨    No  x

As of October 29, 2010, the latest practicable date, the registrant had 13,872,585 shares of Common Stock, $0.001 par value per share, outstanding.

 

 

 


Table of Contents

 

EXPONENT, INC.

FORM 10-Q

TABLE OF CONTENTS

 

         Page  
PART I – FINANCIAL INFORMATION   

Item 1.

  Financial Statements (unaudited):   
 

Condensed Consolidated Balance Sheets October 1, 2010 and January 1, 2010

     3   
 

Condensed Consolidated Statements of Income Three and Nine Months Ended October 1, 2010 and October 2, 2009

     4   
 

Condensed Consolidated Statements of Comprehensive Income Three and Nine Months Ended October 1, 2010 and October 2, 2009

     5   
 

Condensed Consolidated Statements of Cash Flows Three and Nine Months Ended October 1, 2010 and October 2, 2009

     6   
 

Notes to Condensed Consolidated Financial Statements

     7   

Item 2.

  Management’s Discussion and Analysis of Financial Condition and Results of Operations      17   

Item 3.

  Quantitative and Qualitative Disclosures About Market Risk      26   

Item 4.

  Controls and Procedures      26   
PART II – OTHER INFORMATION   

Item 1A.

  Risk Factors      27   

Item 2.

  Unregistered Sales of Equity Securities and Use of Proceeds      30   

Item 6.

  Exhibits      30   

Signatures

       31   

 

2


Table of Contents

 

PART I – FINANCIAL INFORMATION

 

Item 1. Financial Statements

EXPONENT, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

October 1, 2010 and January 1, 2010

(in thousands, except share data)

(unaudited)

 

     October 1,     January 1,  
     2010     2010  
Assets     

Current assets:

    

Cash and cash equivalents

   $ 92,071      $ 67,895   

Short-term investments

     —          7,490   

Accounts receivable, net of allowance for doubtful accounts of $2,725 and $2,717 at October 1, 2010 and January 1, 2010, respectively

     71,015        62,662   

Prepaid expenses and other assets

     3,938        5,789   

Deferred income taxes

     5,392        4,494   
                

Total current assets

     172,416        148,330   

Property, equipment and leasehold improvements, net

     27,810        29,115   

Goodwill

     8,607        8,607   

Deferred income taxes

     12,296        10,476   

Other assets

     14,221        9,953   
                

Total assets

   $ 235,350      $ 206,481   
                
Liabilities and Stockholders’ Equity     

Current liabilities:

    

Accounts payable and accrued liabilities

   $ 6,554      $ 4,498   

Accrued payroll and employee benefits

     32,611        35,822   

Deferred revenues

     5,197        4,757   
                

Total current liabilities

     44,362        45,077   

Other liabilities

     392        367   

Deferred compensation

     13,852        9,543   

Deferred rent

     2,010        1,423   
                

Total liabilities

     60,616        56,410   
                

Stockholders’ equity:

    

Common stock, $0.001 par value; 100,000,000 shares authorized; 16,426,664 shares issued at October 1, 2010 and January 1, 2010

     16        16   

Additional paid-in capital

     93,587        83,808   

Accumulated other comprehensive loss

     (354     (367

Retained earnings

     153,103        139,606   

Treasury stock, at cost; 2,568,966 and 2,690,206 shares held at October 1, 2010 and January 1, 2010, respectively

     (71,618     (72,992
                

Total stockholders’ equity

     174,734        150,071   
                

Total liabilities and stockholders’ equity

   $ 235,350      $ 206,481   
                

The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.

 

3


Table of Contents

 

EXPONENT, INC.

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

For the Three and Nine Months Ended October 1, 2010 and October 2, 2009

(in thousands, except per share data)

(unaudited)

 

     Three Months Ended      Nine Months Ended  
     October 1,
2010
     October 2,
2009
     October 1,
2010
     October 2,
2009
 

Revenues:

           

Revenues before reimbursements

   $ 56,906       $ 50,666       $ 167,235       $ 158,026   

Reimbursements

     9,400         4,579         18,916         17,877   
                                   

Revenues

     66,306         55,245         186,151         175,903   
                                   

Operating expenses:

           

Compensation and related expenses

     36,960         34,571         108,800         107,371   

Other operating expenses

     5,365         5,331         15,972         15,917   

Reimbursable expenses

     9,400         4,579         18,916         17,877   

General and administrative expenses

     3,011         2,379         8,611         8,238   
                                   

Total operating expenses

     54,736         46,860         152,299         149,403   
                                   

Operating income

     11,570         8,385         33,852         26,500   

Other income (expense), net:

           

Interest income, net

     36         93         165         527   

Miscellaneous income (expense), net

     1,597         1,209         1,997         2,265   
                                   

Total other income (expense), net

     1,633         1,302         2,162         2,792   
                                   

Income before income taxes

     13,203         9,687         36,014         29,292   

Income taxes

     5,383         3,854         14,675         11,676   
                                   

Net income

   $ 7,820       $ 5,833       $ 21,339       $ 17,616   
                                   

Net income per share:

           

Basic

   $ 0.54       $ 0.41       $ 1.49       $ 1.24   

Diluted

   $ 0.52       $ 0.39       $ 1.42       $ 1.17   

Shares used in per share computations:

           

Basic

     14,385         14,241         14,325         14,167   

Diluted

     15,053         15,028         15,036         15,029   

The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.

 

4


Table of Contents

 

EXPONENT, INC.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

For the Three and Nine Months Ended October 1, 2010 and October 2, 2009

(in thousands)

(unaudited)

 

     Three Months Ended      Nine Months Ended  
     October 1,
2010
    October 2,
2009
     October 1,
2010
    October 2,
2009
 

Net income

   $ 7,820      $ 5,833       $ 21,339      $ 17,616   

Other comprehensive income (loss):

         

Foreign currency translation adjustments, net of tax

     395        91         44        (67

Unrealized (loss) gain on investments, net of tax

     (3     —           (31     116   
                                 

Comprehensive income

   $ 8,212      $ 5,924       $ 21,352      $ 17,665   
                                 

The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.

 

5


Table of Contents

 

EXPONENT, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

For the Nine Months Ended October 1, 2010 and October 2, 2009

(in thousands)

(unaudited)

 

     Nine Months Ended  
     October 1,
2010
    October 2,
2009
 

Cash flows from operating activities:

    

Net income

   $ 21,339      $ 17,616   

Adjustments to reconcile net income to net cash provided by operating activities:

    

Depreciation and amortization of property, equipment and leasehold improvements

     3,235        3,272   

Amortization of premiums and accretion of discounts on short-term investments

     35        150   

Deferred rent

     587        (334

Allowance for doubtful accounts

     1,611        3,253   

Stock-based compensation

     7,332        6,437   

Deferred income tax provision

     (2,551     (3,482

Tax benefit for stock plans

     (2,373     (2,981

Changes in operating assets and liabilities:

    

Accounts receivable

     (9,964     (9,714

Prepaid expenses and other assets

     (1,588     (1,632

Accounts payable and accrued liabilities

     4,675        820   

Accrued payroll and employee benefits

     275        (5,679

Deferred revenues

     440        (1,048
                

Net cash provided by operating activities

     23,053        6,678   
                

Cash flows from investing activities:

    

Capital expenditures

     (1,930     (1,663

Sale/maturity of short-term investments

     7,405        16,933   
                

Net cash provided by investing activities

     5,475        15,270   
                

Cash flows from financing activities:

    

Tax benefit for stock plans

     2,373        2,981   

Payroll taxes for restricted stock units

     (1,918     (1,849

Repurchase of common stock

     (7,129     (9,692

Exercise of share-based payment awards

     2,331        2,443   
                

Net cash used in financing activities

     (4,343     (6,117
                

Effect of foreign currency exchange rates on cash and cash equivalents

     (9     84   
                

Net increase in cash and cash equivalents

     24,176        15,915   

Cash and cash equivalents at beginning of period

     67,895        32,598   
                

Cash and cash equivalents at end of period

   $ 92,071      $ 48,513   
                

The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.

 

6


Table of Contents

 

EXPONENT, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the Three and Nine Months Ended October 1, 2010 and October 2, 2009

Note 1: Basis of Presentation

Exponent, Inc. (referred to as the “Company” or “Exponent”) is an engineering and scientific consulting firm that provides solutions to complex problems. The Company operates on a 52-53 week fiscal year ending on the Friday closest to the last day of December.

The accompanying unaudited condensed consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information, the instructions to Form 10-Q and Article 10 of Regulation S-X of the Securities and Exchange Commission. Accordingly, they do not contain all the information and notes required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of management, all adjustments which are necessary for the fair presentation of the condensed consolidated financial statements have been included and all such adjustments are of a normal and recurring nature. The operating results for the three and nine months ended October 1, 2010 are not necessarily representative of the results of future quarterly or annual periods. The following information should be read in conjunction with the audited consolidated financial statements and accompanying notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended January 1, 2010.

The unaudited condensed consolidated financial statements include the accounts of Exponent, Inc. and its subsidiaries which are wholly owned. All intercompany accounts and transactions have been eliminated in consolidation.

Authorized Capital Stock. The Company committed to stockholders in a letter dated May 23, 2006 to limit its use of authorized capital stock to 40 million common shares, and 2 million preferred shares, unless the approval of the Company’s stockholders is obtained subsequently, such as through a further amendment to the Company’s authorized capital stock.

Use of Estimates. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Actual results could differ from those estimates.

 

7


Table of Contents

EXPONENT, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

For the Three and Nine Months Ended October 1, 2010 and October 2, 2009

 

Note 2: Fair Value Measurements

The Company measures certain financial assets and liabilities at fair value on a recurring basis, including available-for-sale fixed income securities, trading fixed income and equity securities held in its deferred compensation plan and the liability associated with its deferred compensation plan. The fair value of these certain financial assets and liabilities was determined using the following inputs at October 1, 2010 (in thousands):

 

     Fair Value Measurements at Reporting Date Using  
     Total      Quoted Prices in
Active Markets for
Identical Assets

(Level 1)
     Significant Other
Observable Inputs

(Level 2)
     Significant
Unobservable
Inputs

(Level 3)
 

Assets

           

Fixed income available-for-sale securities (1)

   $ 64,755       $ 64,755       $ —           —     

Fixed income trading securities held in deferred compensation plan (2)

     5,072         5,072         —           —     

Equity trading securities held in deferred compensation plan (2)

     9,049         9,049         —           —     
                                   

Total

   $ 78,876       $ 78,876       $ —         $ —     
                                   

Liabilities

           

Deferred compensation plan (3)

     14,121         14,121         —           —     
                                   

Total

   $ 14,121       $ 14,121       $ —         $ —     
                                   

 

(1)

Included in cash and cash equivalents on the Company’s condensed consolidated balance sheet.

(2)

Included in other current assets and other assets on the Company’s condensed consolidated balance sheet.

(3)

Included in accrued liabilities and deferred compensation on the Company’s condensed consolidated balance sheet.

 

8


Table of Contents

EXPONENT, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

For the Three and Nine Months Ended October 1, 2010 and October 2, 2009

 

The fair value of these certain financial assets and liabilities was determined using the following inputs at January 1, 2010 (in thousands):

 

     Fair Value Measurements at Reporting Date Using  
     Total      Quoted Prices in
Active Markets for
Identical Assets

(Level 1)
     Significant Other
Observable Inputs

(Level 2)
     Significant
Unobservable
Inputs

(Level 3)
 

Assets

           

Fixed income available-for-sale securities (1)

   $ 64,416       $ 56,926       $ 7,490         —     

Fixed income trading securities held in deferred compensation plan (2)

     2,873         2,873         —           —     

Equity trading securities held in deferred compensation plan (2)

     6,960         6,960         —           —     
                                   

Total

   $ 74,249       $ 66,759       $ 7,490       $ —     
                                   

Liabilities

           

Deferred compensation plan (3)

     9,833         9,833         —           —     
                                   

Total

   $ 9,833       $ 9,833       $ —         $ —     
                                   

 

(1)

Included in cash and cash equivalents and short-term investments on the Company’s condensed consolidated balance sheet.

(2)

Included in other current assets and other assets on the Company’s condensed consolidated balance sheet.

(3)

Included in accrued liabilities and deferred compensation on the Company’s condensed consolidated balance sheet.

The valuation techniques used to measure the fair value of our financial instruments having Level 2 inputs were derived from non-binding market consensus prices that are corroborated by observable market data and quoted market prices for similar instruments.

At October 1, 2010, fixed income available-for-sale securities consist of $64,755,000 of money market securities classified as cash equivalents. Fixed income and equity trading securities are composed of mutual funds held in the Company’s deferred compensation plan. See Note 7 for additional information about the Company’s deferred compensation plan.

At October 1, 2010, the Company did not have any assets valued using significant other observable inputs (Level 2) or significant unobservable inputs (Level 3).

Fixed income available-for-sale securities at January 1, 2010 represent obligations of state and local government agencies and money market securities.

The carrying amount of the Company’s accounts receivable, other assets and accounts payable approximates their fair values. There were no other-than temporary impairments or credit losses related to available-for-sale securities during the first nine months of 2010 and 2009.

 

9


Table of Contents

EXPONENT, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

For the Three and Nine Months Ended October 1, 2010 and October 2, 2009

 

Note 3: Revenue Recognition

The Company derives its revenues primarily from professional fees earned on consulting engagements, product sales in its technology development practice and fees earned for the use of its equipment and facilities, as well as reimbursements for outside direct expenses associated with the services that are billed to its clients.

Exponent reports revenues net of subcontractor fees. The Company has determined that it is not the primary obligor with respect to its subcontractors because:

 

   

its clients are directly involved in the subcontractor selection process;

 

   

the subcontractor is responsible for fulfilling the scope of work; and

 

   

the Company passes through the costs of subcontractor agreements with only a minimal fixed percentage mark-up to compensate it for processing the transactions.

Reimbursements, including those related to travel and other out-of-pocket expenses, and other similar third-party costs such as the cost of materials, are included in revenues, and an equivalent amount of reimbursable expenses are included in operating expenses. Any mark-up on reimbursable expenses is included in revenues.

Substantially all of the Company’s engagements are performed under time and material or fixed-price billing arrangements. On time and material and fixed-price projects, revenue is generally recognized as the services are performed. For substantially all of the Company’s fixed-price engagements, it recognizes revenue based on the relationship of incurred labor hours at standard rates to its estimate of the total labor hours at standard rates it expects to incur over the term of the contract. The Company believes this methodology achieves a reliable measure of the revenue from the consulting services it provides to its customers under fixed-price contracts given the nature of the consulting services the Company provides and the following additional considerations:

 

   

the Company considers labor hours at standard rates and expenses to be incurred when pricing its contracts;

 

   

the Company generally does not incur set-up costs on its contracts;

 

   

the Company does not believe that there are reliable milestones by which to measure progress toward completion;

 

   

if the contract is terminated early, the customer is required to pay the Company for time at standard rates plus materials incurred to date;

 

   

the Company does not recognize revenue for award fees or bonuses until specific contractual criteria are met;

 

   

the Company does not include revenue for unpriced change orders until the customer agrees with the changes;

 

   

historically the Company has not had significant accounts receivable write-offs or cost overruns; and

 

   

its contracts are typically progress billed on a monthly basis.

Product revenue is recognized when both title and risk of loss transfer to the customer and customer acceptance has occurred, provided that no significant obligations remain. Revenue from multiple-element arrangements is allocated based on the relative fair value of each element, which is generally based on the relative sales price for each element when sold separately. If the fair value of one or more delivered elements cannot be determined, then revenue is allocated based on the residual method.

 

10


Table of Contents

EXPONENT, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

For the Three and Nine Months Ended October 1, 2010 and October 2, 2009

 

Gross revenues and reimbursements for the three and nine months ended October 1, 2010 and October 2, 2009 were as follows:

 

     Three Months Ended      Nine Months Ended  

(In thousands)

   October 1,
2010
     October 2,
2009
     October 1,
2010
     October 2,
2009
 

Gross revenues

   $ 69,752       $ 57,619       $ 194,274       $ 180,802   

Less: Subcontractor fees

     3,446         2,374         8,123         4,899   
                                   

Revenues

     66,306         55,245         186,151         175,903   

Reimbursements:

           

Out-of-pocket travel reimbursements

     1,220         1,105         3,486         3,466   

Other outside direct expenses

     8,180         3,474         15,430         14,411   
                                   
     9,400         4,579         18,916         17,877   
                                   

Revenues before reimbursements

   $ 56,906       $ 50,666       $ 167,235       $ 158,026   
                                   

Significant management judgments and estimates must be made and used in connection with the revenue recognized in any accounting period. These judgments and estimates include an assessment of collectability and, for fixed-price engagements, an estimate as to the total effort required to complete the project. If the Company made different judgments or utilized different estimates, the amount and timing of its revenue for any period could be materially different.

All consulting contracts are subject to review by management, which requires a positive assessment of the collectability of contract amounts. If, during the course of the contract, the Company determines that collection of revenue is not reasonably assured, it does not recognize the revenue until its collection becomes reasonably assured, which is generally upon receipt of cash. The Company assesses collectability based on a number of factors, including past transaction history with the client and project manager, as well as the creditworthiness of the client. Losses on fixed-price contracts are recognized during the period in which the loss first becomes evident. Contract losses are determined to be the amount by which the estimated total costs of the contract exceeds the total fixed price of the contract.

Note 4: Net Income Per Share

Basic per share amounts are computed using the weighted-average number of common shares outstanding during the period. Diluted per share amounts are calculated using the weighted-average number of common shares outstanding during the period and, when dilutive, the weighted-average number of potential common shares from the issuance of common stock to satisfy outstanding restricted stock units and the exercise of outstanding options to purchase common stock using the treasury stock method.

The following schedule reconciles the shares used to calculate basic and diluted net income per share:

 

     Three Months Ended      Nine Months Ended  

(In thousands)

   October 1,
2010
     October 2,
2009
     October 1,
2010
     October 2,
2009
 

Shares used in basic per share computation

     14,385         14,241         14,325         14,167   

Effect of dilutive common stock options outstanding

     266         420         299         485   

Effect of dilutive restricted stock units outstanding

     402         367         412         377   
                                   

Shares used in diluted per share computation

     15,053         15,028         15,036         15,029   
                                   

Common stock options to purchase 0 and 60,000 shares were excluded from the diluted per share calculation for the three months ended October 1, 2010 and October 2, 2009, respectively, due to their antidilutive effect. The weighted-average exercise price for the antidilutive shares was $31.01 for the three months ended

 

11


Table of Contents

EXPONENT, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

For the Three and Nine Months Ended October 1, 2010 and October 2, 2009

 

October 2, 2009. Common stock options to purchase 60,000 shares were excluded from the diluted per share calculation for the nine months ended October 1, 2010 and October 2, 2009, respectively, due to their antidilutive effect. The weighted-average exercise price for the antidilutive shares was $31.01 for the nine months ended October 1, 2010 and October 2, 2009, respectively.

Note 5: Stock-Based Compensation

Restricted Stock Units

Restricted stock unit grants are designed to attract and retain employees, and to better align employee interests with those of the Company’s stockholders. For a select group of employees, up to 40% of their annual bonus is settled with fully vested restricted stock unit awards. Under these fully vested restricted stock unit awards, the holder of each award has the right to receive one share of the Company’s common stock for each fully vested restricted stock unit four years from the date of grant. Each individual who receives a fully vested restricted stock unit award is also granted a matching number of unvested restricted stock unit awards. Unvested restricted stock unit awards are also granted for select new hires and promotions. These unvested restricted stock unit awards generally cliff vest four years from the date of grant, at which time the holder of each award will have the right to receive one share of the Company’s common stock for each restricted stock unit award provided the holder of each award has met certain employment conditions. In the case of retirement at 59 1/2 years or older, all unvested restricted stock unit awards will continue to vest, provided that the holder of each award does all consulting work through the Company and does not become an employee for a past or present client, beneficial party or competitor of the Company.

The value of these restricted stock unit awards is determined based on the market price of the Company’s common stock on the date of grant. The value of fully vested restricted stock unit awards issued is recorded as a reduction to accrued bonuses. The portion of bonus expense that the Company expects to settle with fully vested restricted stock unit awards is recorded as stock-based compensation during the period the bonus is earned. The Company recorded stock-based compensation expense associated with accrued bonus awards of $1,259,000 and $968,000 during the three months ended October 1, 2010 and October 2, 2009, respectively. For the nine months ended October 1, 2010 and October 2, 2009, the Company recorded stock-based compensation expense associated with accrued bonus awards of $3,495,000 and $3,051,000, respectively. The value of the unvested restricted stock unit awards granted is recognized on a straight-line basis over the shorter of the four-year vesting period or the period between the grant date and the date the award recipient turns 59 1/2. If the award recipient is 59 1/2 years or older on the date of grant, the value of the entire award is expensed upon grant. The Company recorded stock-based compensation expense associated with the unvested restricted stock unit awards of $818,000 and $562,000 during the three months ended October 1, 2010 and October 2, 2009, respectively. The Company recorded stock-based compensation expense associated with the unvested restricted stock unit awards of $3,356,000 and $2,886,000 during the nine months ended October 1, 2010 and October 2, 2009, respectively.

Stock Options

Stock options are granted for terms of ten years and generally vest 25% per year over a four-year period from the grant date. The Company grants options at exercise prices equal to the fair value of the Company’s common stock on the date of grant. The Company recorded stock-based compensation expense of $162,000 and $163,000 during the three months ended October 1, 2010 and October 2, 2009, respectively, associated with stock option grants. The Company recorded stock-based compensation expense of $481,000 and $500,000 during the nine months ended October 1, 2010 and October 2, 2009, respectively, associated with stock option grants.

The Company uses the Black-Scholes option-pricing model to determine the fair value of options granted. The determination of the fair value of stock-based awards on the date of grant using an option-pricing model is affected by the Company’s stock price as well as assumptions regarding a number of complex and subjective variables. These variables include expected stock price volatility over the term of the award, actual and projected employee stock option exercise behaviors, the risk-free interest rate and expected dividends.

 

12


Table of Contents

EXPONENT, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

For the Three and Nine Months Ended October 1, 2010 and October 2, 2009

 

The Company used historical exercise and post-vesting forfeiture and expiration data to estimate the expected term of options granted. The historical volatility of the Company’s common stock over a period of time equal to the expected term of the options granted was used to estimate expected volatility. The risk-free interest rate used in the option-pricing model was based on United States Treasury zero-coupon issues with remaining terms similar to the expected term on the options. The Company does not anticipate paying any cash dividends in the foreseeable future and therefore used an expected dividend yield of zero in the option-pricing model. The Company is required to estimate forfeitures at the time of grant and revise those estimates in subsequent periods if actual forfeitures differ from those estimates. Historical data was used to estimate pre-vesting option forfeitures and stock-based compensation expense was recorded only for those awards that are expected to vest. All share-based payment awards are recognized on a straight-line basis over the requisite service periods of the awards.

Note 6: Treasury Stock

On May 22, 2007, the Company’s Board of Directors approved up to $35 million for repurchases of the Company’s common stock. On May 29, 2008, the Company’s Board of Directors authorized an additional $35 million for repurchases of the Company’s common stock. On February 19, 2009, the Company’s Board of Directors authorized an additional $25.1 million for the repurchase of the Company’s common stock.

The Company repurchased 243,802 shares of its common stock for $6.9 million during the nine months ended October 1, 2010. The Company repurchased 433,900 shares of its common stock for $10.2 million during the nine months ended October 2, 2009. As of October 1, 2010, the Company had remaining authorization under its stock repurchase plans of $15.0 million to repurchase shares of common stock.

The Company reissued 365,042 shares of its treasury stock with a cost of $8.3 million to settle restricted stock unit awards, stock options and purchases under the Employee Stock Purchase Plan during the nine months ended October 1, 2010. The Company reissued 488,040 shares of its treasury stock with a cost of $9.3 million to settle restricted stock unit awards, stock options and purchases under the Employee Stock Purchase Plan during the nine months ended October 2, 2009.

Note 7: Deferred Compensation Plan

The Company maintains a nonqualified deferred compensation plan for the benefit of a select group of highly compensated employees. Under this plan participants may elect to defer up to 100% of their compensation. Company assets that are earmarked to pay benefits under the plan are held in a rabbi trust and are subject to the claims of the Company’s creditors. As of October 1, 2010 and January 1, 2010, the invested amounts under the plan totaled $14.1 million and $9.8 million, respectively. These assets are classified as trading securities and are recorded at fair market value with changes recorded as adjustments to other income and expense.

As of October 1, 2010 and January 1, 2010, vested amounts due under the plan totaled $14.1 million and $9.8 million, respectively. Changes in the liability are recorded as adjustments to compensation expense. During the three and nine months ended October 1, 2010, the Company recognized an increase to compensation expense of $1,206,000 and $894,000, respectively, as a result of changes in the market value of the trust assets, with the same amount being recorded as other income. During the three and nine months ended October 2, 2009, the Company recognized an increase to compensation expense of $885,000 and $1,340,000, respectively, as a result of changes in the market value of the trust assets, with the same amount being recorded as other income.

 

13


Table of Contents

EXPONENT, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

For the Three and Nine Months Ended October 1, 2010 and October 2, 2009

 

Note 8: Supplemental Cash Flow Information

The following is supplemental disclosure of cash flow information:

 

     Nine Months Ended  

(In thousands)

   October 1,
2010
    October 2,
2009
 

Cash paid during period:

    

Income taxes

   $ 12,566      $ 12,439   

Non-cash investing and financing activities:

    

Unrealized (loss) gain on short-term investments

   $ (31   $ 116   

Vested stock unit awards issued to settle accrued bonuses

   $ 3,566      $ 3,739   

Stock repurchases payable to broker

   $ —        $ 489   

Note 9: Accounts Receivable, Net

At October 1, 2010 and January 1, 2010, accounts receivable, net, was comprised of the following:

 

     October 1,     January 1,  

(In thousands)

   2010     2010  

Billed accounts receivable

   $ 43,468      $ 46,461   

Unbilled accounts receivable

     30,272        18,918   

Allowance for doubtful accounts

     (2,725     (2,717
                

Total accounts receivable, net

   $ 71,015      $ 62,662   
                

Note 10: Inventory

At October 1, 2010, the Company had $31,000 of raw materials inventory included in prepaid expenses and other current assets on its condensed consolidated balance sheet. At January 1, 2010, the Company had $143,000 of raw materials inventory included in prepaid expenses and other current assets on the Company’s condensed consolidated balance sheet.

Note 11: Segment Reporting

The Company has two operating segments based on two primary areas of service. One operating segment is a broad service group providing technical consulting in different practices primarily in the areas of impending litigation and technology development. The Company’s other operating segment provides services in the area of environmental and health sciences. This operating segment provides a wide range of consulting services relating to environmental hazards and risks and the impact on both human health and the environment.

Segment information for the three and nine months ended October 1, 2010 and October 2, 2009 follows:

Revenues

 

     Three Months Ended      Nine Months Ended  

(In thousands)

   October 1,
2010
     October 2,
2009
     October 1,
2010
     October 2,
2009
 

Engineering and other scientific

   $ 49,315       $ 41,032       $ 138,023       $ 132,898   

Environmental and health

     16,991         14,213         48,128         43,005   
                                   

Total revenues

   $ 66,306       $ 55,245       $ 186,151       $ 175,903   
                                   

 

14


Table of Contents

EXPONENT, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

For the Three and Nine Months Ended October 1, 2010 and October 2, 2009

 

Operating Income

 

     Three Months Ended     Nine Months Ended  

(In thousands)

   October 1,
2010
    October 2,
2009
    October 1,
2010
    October 2,
2009
 

Engineering and other scientific

   $ 12,944      $ 10,109      $ 38,090      $ 32,891   

Environmental and health

     5,881        4,291        15,528        12,645   
                                

Total segment operating income

     18,825        14,400        53,618        45,536   

Corporate operating expense

     (7,255     (6,015     (19,766     (19,036
                                

Total operating income

   $ 11,570      $ 8,385      $ 33,852      $ 26,500   
                                

Capital Expenditures

 

     Three Months Ended      Nine Months Ended  

(In thousands)

   October 1,
2010
     October 2,
2009
     October 1,
2010
     October 2,
2009
 

Engineering and other scientific

   $ 372       $ 216       $ 1,420       $ 933   

Environmental and health

     37         45         119         132   
                                   

Total segment capital expenditures

     409         261         1,539         1,065   

Corporate capital expenditures

     186         244         391         598   
                                   

Total capital expenditures

   $ 595       $ 505       $ 1,930       $ 1,663   
                                   

Depreciation and Amortization

 

     Three Months Ended      Nine Months Ended  

(In thousands)

   October 1,
2010
     October 2,
2009
     October 1,
2010
     October 2,
2009
 

Engineering and other scientific

   $ 700       $ 692       $ 2,095       $ 2,119   

Environmental and health

     50         53         144         146   
                                   

Total segment depreciation and amortization

     750         745         2,239         2,265   

Corporate depreciation and amortization

     334         348         996         1,007   
                                   

Total depreciation and amortization

   $ 1,084       $ 1,093       $ 3,235       $ 3,272   
                                   

The Company derived 12% of revenues from agencies of the federal government for the three months ended October 1, 2010. No single customer comprised more than 10% of the Company’s revenues for the nine months ended October 1, 2010. No single customer comprised more than 10% of the Company’s revenues for the three months ended October 2, 2009. The Company derived 10% of revenues from agencies of the federal government for the nine months ended October 2, 2009. No single customer comprised more than 10% of the Company’s accounts receivable at October 1, 2010. The federal government comprised 13% of the Company’s accounts receivable at January 1, 2010.

 

15


Table of Contents

EXPONENT, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

For the Three and Nine Months Ended October 1, 2010 and October 2, 2009

 

Note 12: Goodwill

Below is a breakdown of goodwill reported by segment as of October 1, 2010:

 

     Environmental      Engineering and         

(In thousands)

   and health      other scientific      Total  

Goodwill

   $ 8,099       $ 508       $ 8,607   

There were no changes in the carrying amount of goodwill for the three and nine months ended October 1, 2010.

Note 13: Contingencies

In July of 2008, the Company was served with a writ by a former client. The writ did not articulate a claim. The Company met with the former client in November of 2008 and again in January of 2009 and learned in those discussions of potential claims against the Company arising out of the testimony delivered by one of the Company’s employees. The former client claims that this testimony contributed to an adverse verdict against them. The adverse verdict is currently under appeal. Given the uncertainty as to whether the claimant will incur a loss (it may prevail on appeal), whether it will choose to pursue one or more claims against the Company, and the nature of the potential claims against the Company, an estimated loss cannot be determined at this time. The Company believes it has a strong defense against all such potential claims and intends to vigorously defend itself. Further, the Company believes that some of the potential claims would be covered by insurance. Although the Company’s ultimate liability in this matter (if any) cannot be determined, based upon information currently available, the Company believes, after consultation with legal counsel, the ultimate resolution of these potential claims will not have a material adverse effect on its financial condition, results of operations or liquidity.

In March of 2010, a lawsuit was filed against the Company which alleges, among other things, that the Company failed to provide rest and meal periods, failed to furnish accurate itemized wage statements, failed to keep accurate payroll records, incurred waiting time penalties, conducted unfair business practices and failed to comply with certain other California Labor Code requirements. The plaintiff is currently trying to qualify a class of the Company’s California based non-exempt employees. The Company intends to vigorously defend itself. The outcome of this matter is uncertain, and the Company is not able to estimate the amount that may become payable as a result of a judgment or settlement related to this claim. Although the Company’s ultimate liability in this matter (if any) cannot be determined, based on information currently available, the Company believes, after consultation with legal counsel, the ultimate resolution of this claim will not have a material adverse effect on its financial condition, results of operations or liquidity.

In addition to the above matters, the Company is a party to various other legal actions and is contingently liable in connection with claims and contracts arising in the normal course of business, the outcome of which the Company believes, after consultation with legal counsel, will not have a material adverse effect on its financial condition, results of operations or liquidity.

 

16


Table of Contents

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion should be read in conjunction with the unaudited condensed consolidated financial statements and notes thereto included herein and with our audited consolidated financial statements and notes thereto for the fiscal year ended January 1, 2010, which are contained in our fiscal 2009 Annual Report on Form 10-K.

Forward-Looking Statements

This Quarterly Report on Form 10-Q contains certain “forward-looking” statements (as such term is defined in the Private Securities Litigation Reform Act of 1995, and the rules promulgated pursuant to the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended thereto) that are based on the beliefs of the Company’s management, as well as assumptions made by and information currently available to the Company’s management. Such forward-looking statements are subject to the safe harbor created by the Private Securities Litigation Reform Act of 1995. When used in this document and in the documents incorporated herein by reference, the words “anticipate,” “believe,” “estimate,” “expect” and similar expressions, as they relate to the Company or its management, identify such forward-looking statements. Such statements reflect the current views of the Company or its management with respect to future events and are subject to certain risks, uncertainties and assumptions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company’s actual results, performance, or achievements could differ materially from those expressed in, or implied by, any such forward-looking statements. Factors that could cause or contribute to such material differences include the possibility that the demand for our services may decline as a result of changes in general and industry specific economic conditions, the timing of engagements for our services, the effects of competitive services and pricing, the absence of backlog related to our business, our ability to attract and retain key employees, the effect of tort reform and government regulation on our business and liabilities resulting from claims made against us. Additional risks and uncertainties are discussed in our fiscal 2009 Annual Report on Form 10-K under the heading “Risk Factors” and elsewhere in the report. The inclusion of such forward-looking information should not be regarded as a representation by the Company or any other person that the future events, plans, or expectations contemplated by the Company will be achieved. Due to such uncertainties and risks, you are warned not to place undue reliance on such forward-looking statements, which speak only as of the date hereof. The Company does not intend to release publicly any updates or revisions to any such forward-looking statements.

Business Overview

Exponent, Inc. is an engineering and scientific consulting firm that provides solutions to complex problems. Our multidisciplinary team of scientists, physicians, engineers and business consultants brings together more than 90 different technical disciplines to solve complicated issues facing industry and business today. Our services include analysis of product development, product recall, regulatory compliance, and discovery of potential problems related to products, people or property and impending litigation, as well as the development of highly technical new products.

CRITICAL ACCOUNTING ESTIMATES

In preparing our condensed consolidated financial statements, we make assumptions, judgments and estimates that can have a significant impact on our revenue, operating income and net income, as well as on the value of certain assets and liabilities on our consolidated balance sheet. We base our assumptions, judgments and estimates on historical experience and various other factors that we believe to be reasonable under the circumstances. Actual results could differ materially from these estimates under different assumptions or conditions. On a regular basis we evaluate our assumptions, judgments and estimates and make changes accordingly. We believe that the assumptions, judgments and estimates involved in the accounting for revenue recognition and estimating the allowance for doubtful accounts have the greatest potential impact on our consolidated financial statements, so we consider these to be our critical accounting policies. Historically, our assumptions, judgments and estimates relative to our critical accounting policies have not differed materially from actual results. Policies covering revenue recognition and estimating the allowance for doubtful accounts are described in our fiscal 2009 Annual Report on Form 10-K under “Critical Accounting Estimates” and Note 1 (Summary of Significant Accounting Policies) of the Notes to Consolidated Financial Statements.

 

17


Table of Contents

RESULTS OF CONSOLIDATED OPERATIONS

Executive Summary

Revenues for the third quarter of 2010 increased 20% and revenues before reimbursements increased 12% as compared to the same period in the prior year. This growth was due to strong performances in our defense technology development and mechanics and materials practices, as well as our environmental and health groups. We continued to work on a steady flow of reactive projects related to litigation, insurance claims and product recalls for which we were able to perform in-depth scientific research and analysis to determine what happened. We have also continued to assist clients in complying with regulations pertaining to the registration of chemicals used throughout the world. Product sales in our defense technology development practice increased 232% as compared to the same period in the prior year.

Net income increased 34% and diluted earnings per share increased to $0.52 per share as compared to $0.39 per share in the same period last year. We were able to improve profitability and margins by effectively managing headcount over the past year to align our resources with anticipated demand which resulted in improved utilization and increased leverage of our cost structure. Utilization for the third quarter of 2010 increased to 71% as compared to 67% during the same period in the prior year.

For the remainder of 2010 we expect to be focused on selectively hiring new talent consistent with our goal of maintaining or improving utilization, continuing to manage our other operating and general and administrative expenses, generating additional cash from operations, maintaining a strong balance sheet, and undertaking activities such as share repurchases to enhance shareholder value.

Overview of the Three Months Ended October 1, 2010

During the third quarter of 2010, we had a 20% increase in revenues as compared to the same period last year. The increase in revenues was due to an increase in product sales, an increase in billable hours in our environmental and health segment, an increase in reimbursable project related costs for consulting projects in our technology development practice and higher billing rates. Product sales increased 232% to $7.3 million during the third quarter of 2010 as compared to $2.2 million during the same period last year due to an increase in the sale of surveillance systems to the United States Army. Billable hours for the third quarter of 2010 increased 4.0% to 226,351 as compared to 217,694 during the same period last year. The increase in billable hours was due to an increase in activity in the areas of our business that are related to litigation, regulatory compliance pertaining to the registration of chemicals and defense technology development. Reimbursable project related costs for consulting projects in our technology development practice increased 312% to $3.0 million during the third quarter of 2010 as compared to $728,000 during the same period last year due to an increase in activity in this practice. Technical full-time equivalents decreased 2.0% to 614 during the third quarter of 2010 as compared to 627 during the same period last year. Utilization increased to 71% for the third quarter of 2010 as compared to 67% during the same period last year. The increase in utilization was due to our management of headcount to align resources with anticipated demand.

 

18


Table of Contents

 

Three Months Ended October 1, 2010 compared to Three Months Ended October 2, 2009

Revenues

 

     Three Months Ended        

(In thousands)

   October 1,
2010
    October 2,
2009
    Percent
Change
 

Engineering and other scientific

   $ 49,315      $ 41,032        20.2

Percentage of total revenues

     74.4     74.3  

Environmental and health

     16,991        14,213        19.5

Percentage of total revenues

     25.6     25.7  
                  

Total revenues

   $ 66,306      $ 55,245        20.0
                  

The increase in revenues for our engineering and other scientific segment was due to an increase in product sales, an increase in reimbursable project related costs for consulting projects in our technology development practice and higher billing rates, partially offset by a decrease in billable hours. Product sales in our defense technology development practice increased 232% to $7.3 million during the third quarter of 2010 as compared to $2.2 million during the same period last year due to an increase in the sale of surveillance systems to the United States Army. Reimbursable project related costs for consulting projects in our technology development practice increased 312% to $3.0 million during the third quarter of 2010 as compared to $728,000 during the same period last year due to an increase in activity in this practice. During the third quarter of 2010, billable hours for this segment decreased 0.9% to 159,056 as compared to 160,537 during the same period last year. Technical full-time equivalents decreased 4.8% to 435 during the third quarter of 2010 as compared to 457 during the same period last year. Utilization increased to 70% for the third quarter of 2010 as compared to 68% during the same period last year. The increase in utilization was due to our management of headcount to align resources with anticipated demand.

The increase in revenues for our environmental and health segment was driven by an increase in billable hours and higher billing rates. During the third quarter of 2010, billable hours for this segment increased by 17.7% to 67,295 as compared to 57,157 during the same period last year. The increase in billable hours was due to an increase in activity in the areas of our business that are related to litigation and regulatory compliance pertaining to the registration of chemicals. Technical full-time equivalents increased by 5.3% to 179 from 170 for the same period last year. Utilization increased to 72% for the third quarter of 2010 as compared to 65% during the same period last year. The increase in utilization was due to our management of headcount to align resources with anticipated demand.

Compensation and Related Expenses

 

     Three Months Ended        

(In thousands)

   October 1,
2010
    October 2,
2009
    Percent
Change
 

Compensation and related expenses

   $ 36,960      $ 34,571        6.9

Percentage of total revenues

     55.7     62.6  

The increase in compensation and related expenses during the third quarter of 2010 was due to an increase in bonuses and the change in value of assets associated with our deferred compensation plan. Bonuses increased by $1,963,000 due to an increase in profitability. During the third quarter of 2010, compensation and related expenses increased $321,000, with a corresponding increase to other income, net, as compared to the third quarter of 2009 due to a change in the value of assets associated with our deferred compensation plan. This increase consisted of an increase in the value of plan assets of $1,206,000 during the third quarter of 2010 and an increase in the value of plan assets of $885,000 during the third quarter of 2009. Average technical full-time equivalent employees for the third quarter of 2010 were 614. On a sequential basis we expect average technical full-time equivalent employees to slightly grow during the fourth quarter.

 

19


Table of Contents

Other Operating Expenses

 

     Three Months Ended        

(In thousands)

   October 1,
2010
    October 2,
2009
    Percent
Change
 

Other operating expenses

   $ 5,365      $ 5,331        0.6

Percentage of total revenues

     8.1     9.6  

Other operating expenses include facilities-related costs, technical materials, computer-related expenses and depreciation and amortization of property, equipment and leasehold improvements. Other operating expenses remained relatively consistent with the same period in the prior year due to our continuing efforts to manage our cost structure by reducing discretionary spending and negotiating favorable agreements with our vendors. For the remainder of 2010, we will continue to focus on managing our cost structure. We expect other operating expenses to grow slightly as we selectively add new talent and make investments in our corporate infrastructure.

Reimbursable Expenses

 

     Three Months Ended        

(In thousands)

   October 1,
2010
    October 2,
2009
    Percent
Change
 

Reimbursable expenses

   $ 9,400      $ 4,579        105.3

Percentage of total revenues

     14.2     8.3  

The increase in reimbursable expenses was primarily due to an increase in project related costs in our technology development practice. The amount of reimbursable expenses will vary from quarter to quarter depending on the nature of our projects.

General and Administrative Expenses

 

     Three Months Ended        

(In thousands)

   October 1,
2010
    October 2,
2009
    Percent
Change
 

General and administrative expenses

   $ 3,011      $ 2,379        26.6

Percentage of total revenues

     4.5     4.3  

The increase in general and administrative expenses during the third quarter of 2010 was due to an increase in other professional services of $181,000, an increase in travel and meals of $137,000, an increase in personnel expenses of $98,000 and several other individually insignificant increases. The increase in other professional services was due to an increase in business development activities and professional services to assist us with entering the European defense business. The increase in travel and meals was due to an increase in business development activities and a company-wide managers meeting. The increase in personnel expenses was due to an increase in employee development activities and some employee relocation costs. We expect some growth in general and administrative expenses as we continue to invest in business development and employee development activities.

Other Income (Expense), Net

 

     Three Months Ended        

(In thousands)

   October 1,
2010
    October 2,
2009
    Percent
Change
 

Other income (expense), net

   $ 1,633      $ 1,302        25.4

Percentage of total revenues

     2.5     2.4  

 

20


Table of Contents

 

Other income, net, consists primarily of interest income earned on available cash, cash equivalents and short-term investments, changes in the value of assets associated with our deferred compensation plan and rental income from leasing space in our Silicon Valley facility. The increase in other income, net, was due to a change in value of assets associated with our deferred compensation plan. The change in value of assets associated with our deferred compensation plan caused a $321,000 increase in other income, net, with a corresponding increase to compensation expense. This increase consisted of an increase in the value of plan assets of $1,206,000 during the third quarter of 2010 and an increase in the value of plan assets of $885,000 during the third quarter of 2009.

Income Taxes

 

     Three Months Ended        

(In thousands)

   October 1,
2010
    October 2,
2009
    Percent
Change
 

Income taxes

   $ 5,383      $ 3,854        39.7

Percentage of total revenues

     8.1     7.0  

Effective tax rate

     40.8     39.8  

The increase in income tax expense was due to a corresponding increase in pre-tax income and an increase in our effective tax rate. The increase in our effective tax rate was primarily due to a decrease in tax-exempt interest income.

Nine Months Ended October 1, 2010 compared to Nine Months Ended October 2, 2009

Revenues

 

     Nine Months Ended        

(In thousands)

   October 1,
2010
    October 2,
2009
    Percent
Change
 

Engineering and other scientific

   $ 138,023      $ 132,898        3.9

Percentage of total revenues

     74.1     75.6  

Environmental and health

     48,128        43,005        11.9

Percentage of total revenues

     25.9     24.4  
                  

Total revenues

   $ 186,151      $ 175,903        5.8
                  

The increase in revenues for our engineering and other scientific segment was due to higher billing rates and an increase in reimbursable project related costs for consulting projects in our technology development practice, partially offset by a decrease in billable hours. Reimbursable project related costs for consulting projects in our technology development practice increased 14% to $4.8 million during the first nine months of 2010 as compared to $4.2 during the same period last year due to an increase in activity in this practice. During the first nine months of 2010, billable hours for this segment decreased 1.5% to 488,026 as compared to 495,452 during the same period last year. Technical full-time equivalents decreased 4.8% to 439 during the first nine months of 2010 as compared to 461 during the same period last year. Utilization increased to 71% for the first nine months of 2010 as compared to 69% during the same period last year. The increase in utilization was due to our management of headcount to align resources with anticipated demand. Product sales in our defense technology development practice were $9.7 million for the first nine months of 2010 and 2009.

The increase in revenues for our environmental and health segment was driven by an increase in billable hours and higher billing rates. During the first nine months of 2010, billable hours for this segment increased by 10.6% to 192,753 as compared to 174,338 during the same period last year. The increase in billable hours was due to an increase in activity in the areas of our business that are related to litigation and regulatory compliance pertaining to the registration of chemicals. Technical full-time equivalents increased by 2.9% to 176 from 171 for the same period last year. Utilization increased to 70% for the first nine months of 2010 as compared to 65% during the same period last year. The increase in utilization was due to our management of headcount to align resources with anticipated demand.

 

21


Table of Contents

 

Compensation and Related Expenses

 

     Nine Months Ended        

(In thousands)

   October 1,
2010
    October 2,
2009
    Percent
Change
 

Compensation and related expenses

   $ 108,800      $ 107,371        1.3

Percentage of total revenues

     58.4     61.0  

The increase in compensation and related expenses during the first nine months of 2010 was due to an increase in bonuses, partially offset by a decrease in payroll and the change in value of assets associated with our deferred compensation plan. Bonuses increased by $3,519,000 due to an increase in profitability. Payroll decreased by $1,702,000 due to a decrease in technical full-time equivalent employees, partially offset by the impact of our annual salary increase. During the first nine months of 2010, compensation and related expenses decreased $446,000, with a corresponding decrease to other income, net, as compared to the same period last year due to a change in the value of assets associated with our deferred compensation plan. This decrease consisted of an increase in the value of plan assets of $894,000 during the first nine months of 2010 and an increase in the value of plan assets of $1,340,000 during the same period last year.

Other Operating Expenses

 

     Nine Months Ended        

(In thousands)

   October 1,
2010
    October 2,
2009
    Percent
Change
 

Other operating expenses

   $ 15,972      $ 15,917        0.3

Percentage of total revenues

     8.6     9.0  

Other operating expenses include facilities-related costs, technical materials, computer-related expenses and depreciation and amortization of property, equipment and leasehold improvements. Other operating expenses remained relatively consistent with the same period last year due to our continuing efforts to manage our cost structure by reducing discretionary spending and negotiating favorable agreements with our vendors.

Reimbursable Expenses

 

     Nine Months Ended        

(In thousands)

   October 1,
2010
    October 2,
2009
    Percent
Change
 

Reimbursable expenses

   $ 18,916      $ 17,877        5.8

Percentage of total revenues

     10.2     10.2  

The increase in reimbursable expenses was primarily due to an increase in project related costs in our technology development practice. The amount of reimbursable expenses will vary from quarter to quarter depending on the nature of our projects.

General and Administrative Expenses

 

     Nine Months Ended        

(In thousands)

   October 1,
2010
    October 2,
2009
    Percent
Change
 

General and administrative expenses

   $ 8,611      $ 8,238        4.5

Percentage of total revenues

     4.6     4.7  

 

22


Table of Contents

 

The increase in general and administrative expenses during the first nine months of 2010 was due to an increase in travel and meals of $395,000, an increase in other professional services of $214,000 and several other individually insignificant increases partially offset by a decrease in bad debt expense of $554,000. The increase in travel and meals was due to an increase in business development activities and a company-wide managers meeting. The increase in other professional services was due to an increase in business development activities and professional services to assist us with entering the European defense business. The decrease in bad debt expense was primarily due to the 2009 bankruptcy filings of Chrysler and General Motors.

Other Income (Expense), Net

 

     Nine Months Ended        

(In thousands)

   October 1,
2010
    October 2,
2009
    Percent
Change
 

Other income (expense), net

   $ 2,162      $ 2,792        (22.6 )% 

Percentage of total revenues

     1.2     1.6  

Other income, net, consists primarily of interest income earned on available cash, cash equivalents and short-term investments, changes in the value of assets associated with our deferred compensation plan and rental income from leasing space in our Silicon Valley facility. The decrease in other income, net, was due to a change in value of assets associated with our deferred compensation plan and a decrease in interest income. The change in value of assets associated with our deferred compensation plan caused a $446,000 decrease in other income, net with a corresponding decrease to compensation expense. This decrease consisted of an increase in the value of plan assets of $894,000 during the first nine months of 2010 and an increase in the value of plan assets of $1,340,000 during the same period last year. The decrease in interest income of $362,000 was due to a decrease in the average balance of our short-term investments and lower interest rates.

Income Taxes

 

     Nine Months Ended        

(In thousands)

   October 1,
2010
    October 2,
2009
    Percent
Change
 

Income taxes

   $ 14,675      $ 11,676        25.7

Percentage of total revenues

     7.9     6.6  

Effective tax rate

     40.7     39.9  

The increase in income tax expense was due to a corresponding increase in pre-tax income and an increase in our effective tax rate. The increase in our effective tax rate was primarily due to a decrease in tax-exempt interest income.

RECENT ACCOUNTING PRONOUNCEMENTS

In October 2009, the Financial Accounting Standards Board (“FASB”) issued a new revenue recognition standard for arrangements with multiple deliverables. The new standard permits entities to initially use management’s best estimate of selling price to value individual deliverables when those deliverables do not have vendor specific objective evidence of fair value or when third-party evidence is not available. Additionally, the new standard modifies the manner in which the transaction consideration is allocated across the separately identified deliverables by no longer permitting the residual method of allocating arrangement consideration.

Also in October 2009, the FASB amended the accounting standards for revenue recognition to exclude software contained within certain qualifying tangible products from the scope of the software revenue recognition guidance if the software is essential to the tangible product’s functionality.

These new standards are effective for annual periods ending after June 15, 2010 and are effective for us beginning in the first quarter of fiscal 2011; however, early adoption is permitted. We are currently evaluating the impact of adopting these new standards, but do not expect the adoption to have a material impact on our consolidated financial position, results of operations or cash flows.

 

23


Table of Contents

 

LIQUIDITY AND CAPITAL RESOURCES

As of October 1, 2010, our cash, cash equivalents and short-term investments were $92.1 million compared to $75.4 million at January 1, 2010. The following table summarizes our cash flows (in thousands):

 

     Nine Months Ended  
     October 1,
2010
    October 2,
2009
 

Net cash provided by operating activities

   $ 23,053      $ 6,678   

Net cash provided by investing activities

     5,475        15,270   

Net cash used in financing activities

     (4,343     (6,117

The increase in net cash provided by operating activities during the first nine months of 2010 was due to an increase in net income, an increase in accrued payroll and employee benefits and a larger increase in accounts payable and accrued liabilities. Accrued payroll and employee benefits increased $275,000 during the first nine months of 2010 as compared to a decrease of $5.7 million during the same period last year. The increase in accrued payroll and employee benefits was due to an increase in the growth of accrued bonuses due to a corresponding increase in profitability. Accounts payable and accrued liabilities increased by $4.7 million during the first nine months of 2010 as compared to an increase of $820,000 during the same period last year. The larger increase in accounts payable and accrued liabilities was due to the timing of payments to vendors and an increase in activity in our defense technology development business.

The decrease in net cash provided by investing activities was due to a decrease of $9,528,000 in sales and maturities of short-term investments as compared to the same period last year.

The decrease in net cash used in financing activities was primarily due to a decrease in treasury repurchases of $2.6 million.

We expect to continue our investing activities, including purchases of short-term investments and capital expenditures. Furthermore, cash reserves may be used to repurchase common stock under our stock repurchase program or strategically acquire professional services firms that are complementary to our business.

The following schedule summarizes our principal contractual commitments as of October 1, 2010 (in thousands):

 

Fiscal year

   Operating
lease
commitments
     Capital
leases
     Purchase
obligations
     Total  

2010

   $ 1,562       $ 1       $ 5,178       $ 6,741   

2011

     5,765         6         —           5,771   

2012

     5,197         3         —           5,200   

2013

     2,900         2         —           2,902   

2014

     2,465         —           —           2,465   

Thereafter

     3,140         —           —           3,140   
                                   
   $ 21,029       $ 12       $ 5,178       $ 26,219   
                                   

We maintain a nonqualified deferred compensation plan for the benefit of a select group of highly compensated employees. Vested amounts due under the plan of $13.9 million were recorded as a long-term liability on our condensed consolidated balance sheet at October 1, 2010. Company assets that are earmarked to pay benefits under the plan are held in a rabbi trust and are subject to the claims of our creditors. As of October 1, 2010 invested amounts under the plan of $13.9 million were recorded as a long-term asset on our condensed consolidated balance sheet.

 

24


Table of Contents

 

As permitted under Delaware law, we have agreements whereby we indemnify our officers and directors for certain events or occurrences while the officer or director is, or was, serving at our request in such capacity. The indemnification period covers all pertinent events and occurrences during the officer’s or director’s lifetime. The maximum potential amount of future payments we could be required to make under these indemnification agreements is unlimited; however, we have director and officer insurance coverage that reduces our exposure and enables us to recover a portion of any future amounts paid.

We believe that our existing cash, cash equivalents, short-term investments and our anticipated cash flows from operations will be sufficient to meet our anticipated operating requirements for at least the next twelve months.

Non-GAAP Financial Measures

Regulation G, conditions for use of Non-Generally Accepted Accounting Principles (“Non-GAAP”) financial measures, and other SEC regulations define and prescribe the conditions for use of certain Non-GAAP financial information. Generally, a non-GAAP financial measure is a numerical measure of a company’s performance, financial position or cash flow that either excludes or includes amounts that are not normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP. We closely monitor two financial measures, EBITDA and EBITDAS, which meet the definition of Non-GAAP financial measures. We define EBITDA as net income before income taxes, interest income, depreciation and amortization. We define EBITDAS as EBITDA before stock-based compensation. The Company regards EBITDA and EBITDAS as useful measures of operating performance and cash flow to complement operating income, net income and other GAAP financial performance measures. Additionally, management believes that EBITDA and EBITDAS provide meaningful comparisons of past, present and future operating results. These measures are used to evaluate our financial results, develop budgets and determine employee compensation. These measures, however, should be considered in addition to, and not as a substitute or superior to, operating income, cash flows, or other measures of financial performance prepared in accordance with GAAP. A reconciliation of the Non-GAAP measures to the nearest comparable GAAP measure is set forth below.

The following table shows EBITDA as a percentage of revenues before reimbursements for the three and nine months ended October 1, 2010 and October 2, 2009:

 

     Three Months Ended     Nine Months Ended  

(in thousands, except percentages)

   October 1,
2010
    October 2,
2009
    October 1,
2010
    October 2,
2009
 

Revenues before reimbursements

   $ 56,906      $ 50,666      $ 167,235      $ 158,026   

EBITDA

   $ 14,251      $ 10,687      $ 39,084      $ 32,037   

EBITDA as a % of revenues before reimbursements

     25.0     21.1     23.4     20.3

The increase in EBITDA as a percentage of revenues before reimbursements was due to an increase in product sales, improved utilization and leverage of our cost structure.

 

25


Table of Contents

 

The following table is a reconciliation of EBITDA and EBITDAS to the most comparable GAAP measure, net income, for the three and nine months ended October 1, 2010 and October 2, 2009:

 

     Three Months Ended     Nine Months Ended  

(in thousands)

   October 1,
2010
    October 2,
2009
    October 1,
2010
    October 2,
2009
 

Net income

   $ 7,820      $ 5,833      $ 21,339      $ 17,616   

Add back (subtract):

        

Income taxes

     5,383        3,854        14,675        11,676   

Interest income, net

     (36     (93     (165     (527

Depreciation and amortization

     1,084        1,093        3,235        3,272   
                                

EBITDA

     14,251        10,687        39,084        32,037   
                                

Stock-based compensation

     2,239        1,693        7,332        6,437   
                                

EBITDAS

   $ 16,490      $ 12,380      $ 46,416      $ 38,474   
                                

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk

We are exposed to interest rate risk associated with our balances of cash and cash equivalents. We manage our interest rate risk by maintaining an investment portfolio primarily consisting of debt instruments with high credit quality and relatively short average effective maturities in accordance with the Company’s investment policy. The maximum effective maturity of any issue in our portfolio of cash equivalents is 3 years and the maximum average effective maturity of the portfolio cannot exceed 12 months. If interest rates were to instantaneously increase or decrease by 100 basis points, the change in the fair market value of our portfolio of cash equivalents would not have a material impact on our financial statements. We do not use derivative financial instruments in our portfolio. There have not been any material changes during the period covered by this Quarterly Report on Form 10-Q to our interest rate risk exposures, or how these exposures are managed. Notwithstanding our efforts to manage interest rate risk, there can be no assurances that we will be adequately protected against the risks associated with interest rate fluctuations.

We are exposed to some foreign currency exchange rate risk associated with our foreign operations. Given the limited nature of these operations, we believe that any exposure would be minimal. Currently, we do not employ a foreign currency hedging program to mitigate our foreign currency exchange risk as we believe the risks to date have not been significant.

 

Item 4. Controls and Procedures

(a) Evaluation of Disclosure Controls and Procedures

As required by Rule 13a-15(b) of the Securities Exchange Act of 1934, as amended, an evaluation was performed under the supervision and with the participation of the Company’s management, including the Chief Executive Officer and the Chief Financial Officer, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) or 15d-15(e) of the Exchange Act of 1934, as amended) as of the end of the period covered by this quarterly report. Based on that evaluation, the Company’s management, including the Chief Executive Officer and the Chief Financial Officer, concluded that the Company’s disclosure controls and procedures were effective.

We intend to review and evaluate the design and effectiveness of our disclosure controls and procedures on an ongoing basis, to improve our controls and procedures over time and to correct any deficiencies that we may discover in the future. Our goal is to ensure that our senior management has timely access to all material financial and non-financial information concerning our business. While we believe the present design of our disclosure controls and procedures is effective to achieve our goal, future events affecting our business may cause us to significantly modify our disclosure controls and procedures.

(b) Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting during the nine month period ended October 1, 2010, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

26


Table of Contents

 

PART II—OTHER INFORMATION

 

Item 1A. Risk Factors

FACTORS AFFECTING OPERATING RESULTS AND MARKET PRICE OF STOCK

Exponent operates in a rapidly changing environment that involves a number of uncertainties, some of which are beyond our control. These uncertainties include, but are not limited to, those mentioned elsewhere in this report and those set forth below.

Lack of sizable backlog may lead to less predictable, and perhaps lower, future revenues.

Revenues are primarily derived from services provided in response to client requests or events that occur without notice, and engagements, generally billed as services are performed, are terminable or subject to postponement or delay at any time by clients. As a result, backlog at any particular time is small in relation to our quarterly or annual revenues and is not a reliable indicator of revenues for any future periods. Revenues and operating margins for any particular quarter are generally affected by staffing mix, resource requirements and timing and size of engagements.

Failure to attract and retain key employees may adversely affect our business.

Exponent’s business involves the delivery of professional services and is labor-intensive. Our success depends in large part upon our ability to attract, retain and motivate highly qualified technical and managerial personnel. Qualified personnel are in great demand and are likely to remain a limited resource for the foreseeable future. We cannot provide any assurance that we can continue to attract sufficient numbers of highly qualified technical and managerial personnel and to retain existing employees. The loss of key managerial employees, business generators or any significant number of employees could have a material adverse impact on our business, including our ability to secure and complete engagements.

Competition could reduce our pricing and adversely affect our business.

The markets for our services are highly competitive. In addition, there are relatively low barriers to entry into our markets and we have faced, and expect to continue to face, additional competition from new entrants into our markets. Competitive pressure could reduce the market acceptance of our services and result in price reductions that could have a material adverse effect on our business, financial condition or results of operations.

The loss of a large client could adversely affect our business.

We currently derive and believe that we will continue to derive a significant portion of our revenues from clients, organizations and insurers related to the transportation industry and the government sector. The loss of any large client, organization or insurer related to the transportation industry, government sector or any other large client, organization or insurer which is a significant customer, could have a material adverse effect on our business, financial condition or results of operations.

 

27


Table of Contents

 

Our business can be adversely affected by downturns in the overall economy.

The markets that we serve are cyclical and subject to general economic conditions. The direction and relative strength of the global economy continues to be uncertain. If the economic growth in the United States, where we primarily operate, continues to be slow and not improve, our clients may consolidate or go out of business and thus demand for our services could be reduced significantly.

Our clients may be unable to pay for our services.

If a client’s financial difficulties become severe, the client may be unwilling or unable to pay our invoices in the ordinary course of business, which could adversely affect collections of both our accounts receivable and unbilled services. On occasion, some of our clients have entered bankruptcy, which has prevented us from collecting amounts owed to us. The bankruptcy of a client with substantial accounts receivable could have a material adverse effect on our financial condition and results of operations.

We hold substantial investments that could present liquidity risks.

Our cash equivalent portfolio as of October 1, 2010 consisted primarily of obligations of state and local government agencies. We follow an established investment policy to monitor, manage and limit our exposure to interest rate and credit risk. The policy sets forth credit quality standards and limits our exposure to any one issuer, as well as our maximum exposure to various asset classes.

As a result of current adverse financial market conditions, investments in some financial instruments may pose risks arising from liquidity and credit concerns. As of October 1, 2010, we had no impairment charge associated with our investment portfolio relating to such adverse financial market conditions. Although we believe our current investment portfolio has a low risk of impairment, we cannot predict future market conditions or market liquidity and can provide no assurance that our investment portfolio will remain unimpaired.

Our business is dependent on our professional reputation.

The professional reputation of Exponent and its consultants is critical to our ability to successfully compete for new client engagements and attract or retain professionals. Proven or unproven allegations against us may damage our professional reputation. Any factors that damage our professional reputation could have a material adverse effect on our business.

Our business can be adversely impacted by deregulation or reduced regulatory enforcement.

Public concern over health, safety and preservation of the environment has resulted in the enactment of a broad range of environmental and/or other laws and regulations by local, state and federal lawmakers and agencies. These laws and the implementing of new regulations affect nearly every industry, as well as the agencies of federal, state and local governments charged with their enforcement. To the extent changes in such laws, regulations and enforcement or other factors significantly reduce the exposures of manufacturers, owners, service providers and others to liability, the demand for our services may be significantly reduced.

Tort reform can reduce demand for our services.

Several of our practices have a significant concentration in litigation support consulting services. To the extent tort reform reduces the exposure of manufacturers, owners, service providers and others to liability, the demand for our litigation support consulting services may be significantly reduced.

Our quarterly results may vary.

Variations in our revenues and operating results occur from time to time, as a result of a number of factors, such as the significance of client engagements commenced and completed during a quarter, the timing of engagements, the number of working days in a quarter, employee hiring and utilization rates, and integration of

 

28


Table of Contents

companies acquired. Because a high percentage of our expenses, particularly personnel and facilities related expenses, are relatively fixed in advance of any particular quarter, a variation in the timing of the initiation or the completion of our client assignments can cause significant variations in operating results from quarter to quarter.

Our engagements may result in professional or other liability.

Our services typically involve difficult engineering and scientific assignments and carry risks of professional and other liability. Many of our engagements involve matters that could have a severe impact on a client’s business, cause a client to lose significant amounts of money, or prevent a client from pursuing desirable business opportunities. Accordingly, if a client is dissatisfied with our performance, the client could threaten or bring litigation in order to recover damages or to contest its obligation to pay our fees. Litigation alleging that we performed negligently, disclosed client confidential information, lost or damaged evidence, infringed on patents, or otherwise breached our obligations to a client could expose us to significant liabilities to our clients or other third parties or tarnish our reputation.

Potential conflicts of interests may preclude us from accepting some engagements.

We provide litigation support consulting and other services primarily in connection with significant disputes, or other matters that are usually adversarial or that involve sensitive client information. The nature of our consulting services may preclude us from accepting engagements with other potential clients because of conflicts. Accordingly, the nature of our business limits the number of both potential clients and potential engagements.

The market price of our common stock may be volatile.

Many factors could cause the market price of our common stock to rise and fall. These include the risk factors listed above, changes in estimates of our performance or recommendations by securities analysts, future sales of shares of common stock in the public market, market conditions in the industry and economy as a whole, acquisitions or strategic alliances involving us or our competitors, restatement of financial results and changes in accounting principles or methods. In addition, the stock market often experiences significant price fluctuations. These fluctuations are often unrelated to the operating performance of particular companies. These broad market fluctuations may adversely affect the market price of our common stock. When the market price of a company’s stock drops significantly, shareholders often institute securities class action litigation against that company. Any litigation against us could cause us to incur substantial costs, divert the time and attention of our management and other resources, or otherwise harm our business.

Impairment of goodwill may require us to record a significant charge to earnings

On our balance sheet, we have $8.6 million of goodwill subject to periodic testing for impairment. Failure to achieve sufficient levels of cash flow at reporting units, the loss of key employees, or changes to the scope of operations of our business could result in goodwill impairment charges. Our goodwill impairment analysis also includes a comparison of the aggregate estimated fair value of all reporting units to our total market capitalization. Therefore, a significant and sustained decline in our stock price could result in goodwill impairment charges. During times of financial market volatility, significant judgment is required to determine the underlying cause of the decline and whether stock price declines are short-term in nature or indicative of an event or change in circumstances.

Impairment of long-lived assets or restructuring activities may require us to record a significant charge to earnings

Our long-lived assets, including our office and laboratory space in Menlo Park, California and our test and engineering center in Phoenix, Arizona, are subject to periodic testing for impairment. Failure to achieve sufficient levels of cash flow at reporting units could result in impairment of our long-lived assets. In addition, we have operating lease commitments for office, warehouse and laboratory space of $19.3 million as of October 1, 2010. Changes in the business environment could lead to changes in the scope of operations of our business. These changes, including the closure of one or more offices, could result in restructuring and/or asset impairment charges.

 

29


Table of Contents

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

The following table provides information on the Company’s repurchases of the Company’s common stock for the three months ended October 1, 2010:

 

(In thousands, except price per share)

   Total
Number of
Shares
Purchased
     Average
Price Paid
Per Share
     Total Number of
Shares Purchased as
Part of Publicly
Announced
Programs
     Approximate Dollar
Value of Shares That
May Yet Be
Purchased Under the
Programs (1)
 

July 3 to July 30

     —         $ —           —         $ 15,769   

July 31 to August 27

     —           —           —         $ 15,769   

August 28 to October 1

     24         31.94         24       $ 14,995   
                             

Total

     24       $ 31.94         24       $ 14,995   
                             

 

(1)

On May 22, 2007, the Company’s Board of Directors approved up to $35 million for repurchases of the Company’s common stock. On May 29, 2008, the Company’s Board of Directors authorized an additional $35 million for repurchases of the Company’s common stock. On February 19, 2009, the Company’s Board of Directors authorized an additional $25.1 million for repurchases of the Company’s common stock. These plans have no expiration date.

 

Item 6. Exhibits

 

(a) Exhibit Index

 

31.1    Certification of Chief Executive Officer pursuant to Rule 13a – 14(a) under the Securities Exchange Act of 1934.
31.2    Certification of Chief Financial Officer pursuant to Rule 13a – 14(a) under the Securities Exchange Act of 1934.
32.1    Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350.
32.2    Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350.

 

30


Table of Contents

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

      EXPONENT, INC.
      (Registrant)
Date: November 5, 2010      
     

/S/    PAUL R. JOHNSTON        

      Paul R. Johnston, Ph.D., Chief Executive Officer
     

/S/    RICHARD L. SCHLENKER        

      Richard L. Schlenker, Chief Financial Officer

 

31